AC

Aisling Capital Portfolio holdings

AUM $45.3M
This Quarter Return
+49.72%
1 Year Return
-15.24%
3 Year Return
+386.13%
5 Year Return
+1,047.82%
10 Year Return
–
AUM
$584M
AUM Growth
+$584M
Cap. Flow
-$6.64M
Cap. Flow %
-1.14%
Top 10 Hldgs %
97.28%
Holding
17
New
–
Increased
1
Reduced
2
Closed
1

Top Buys

1
ASXC
Asensus Surgical, Inc.
ASXC
$1.42M

Top Sells

1
TTOO
T2 Biosystems, Inc
TTOO
$4.2M
2
XENT
Intersect ENT, Inc
XENT
$3.86M

Sector Composition

1 Healthcare 79.05%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
LOXO
1
DELISTED
Loxo Oncology, Inc
LOXO
$336M 57.53% 4,188,920 – –
AIMT
2
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$61.5M 10.53% 2,990,000 – –
VRAY
3
DELISTED
ViewRay, Inc.
VRAY
$48.4M 8.29% 7,480,887 – –
ESPR icon
4
Esperion Therapeutics
ESPR
$448M
$38.7M 6.64% 837,125 – –
ARAV
5
DELISTED
Aravive, Inc. Common Stock
ARAV
$35.3M 6.05% 2,024,465 – –
ADMA icon
6
ADMA Biologics
ADMA
$4.12B
$13.4M 2.29% 3,608,171 – –
PRTK
7
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$11.6M 1.99% 482,680 – –
SYRS
8
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$8.18M 1.4% 508,565 – –
CDTX icon
9
Cidara Therapeutics
CDTX
$1.66B
$7.66M 1.31% 1,021,148 – –
ASXC
10
DELISTED
Asensus Surgical, Inc.
ASXC
$7.34M 1.26% 10,335,819 +2,000,000 +24% +$1.42M
AGRX
11
DELISTED
Agile Therapeutics, Inc
AGRX
$6.77M 1.16% 1,804,933 – –
TTOO
12
DELISTED
T2 Biosystems, Inc
TTOO
$4.89M 0.84% 1,523,499 -1,307,493 -46% -$4.2M
CMRX
13
DELISTED
Chimerix, Inc.
CMRX
$2.58M 0.44% 472,943 – –
PTX
14
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$844K 0.14% 210,000 – –
XENT
15
DELISTED
Intersect ENT, Inc
XENT
– – -225,000 Closed -$3.86M
ZLTQ
16
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$0 ﹤0.01% 11,985 -1,597,742 -99% –